These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 15464127)

  • 21. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
    Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
    Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Individual differences in cocaine- and amphetamine-induced activation of male Sprague-Dawley rats: contribution of the dopamine transporter.
    Briegleb SK; Gulley JM; Hoover BR; Zahniser NR
    Neuropsychopharmacology; 2004 Dec; 29(12):2168-79. PubMed ID: 15292903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of dopamine and psychoactive drugs on dopamine transporter phosphorylation and regulation.
    Gorentla BK; Vaughan RA
    Neuropharmacology; 2005 Nov; 49(6):759-68. PubMed ID: 16181646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
    Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
    Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine transporters participate in the physiological regulation of prolactin.
    Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
    Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging.
    Lindsey KP; Wilcox KM; Votaw JR; Goodman MM; Plisson C; Carroll FI; Rice KC; Howell LL
    J Pharmacol Exp Ther; 2004 Jun; 309(3):959-69. PubMed ID: 14982963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of a rationally designed, low abuse potential, biogenic amine releaser that suppresses cocaine self-administration.
    Rothman RB; Blough BE; Woolverton WL; Anderson KG; Negus SS; Mello NK; Roth BL; Baumann MH
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1361-9. PubMed ID: 15761112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A genetic screen in Caenorhabditis elegans for dopamine neuron insensitivity to 6-hydroxydopamine identifies dopamine transporter mutants impacting transporter biosynthesis and trafficking.
    Nass R; Hahn MK; Jessen T; McDonald PW; Carvelli L; Blakely RD
    J Neurochem; 2005 Aug; 94(3):774-85. PubMed ID: 15992384
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the dopamine transporter in the differential cocaine-induced locomotor activation of inbred long-sleep and short-sleep mice.
    Hanania T; Gulley JM; Salaz DO; Larson GA; Zahniser NR
    Neuropsychopharmacology; 2004 Oct; 29(10):1814-22. PubMed ID: 15199369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Individual differences in response to novelty predict prefrontal cortex dopamine transporter function and cell surface expression.
    Zhu J; Bardo MT; Bruntz RC; Stairs DJ; Dwoskin LP
    Eur J Neurosci; 2007 Aug; 26(3):717-28. PubMed ID: 17651428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Environmental enrichment decreases cell surface expression of the dopamine transporter in rat medial prefrontal cortex.
    Zhu J; Apparsundaram S; Bardo MT; Dwoskin LP
    J Neurochem; 2005 Jun; 93(6):1434-43. PubMed ID: 15935059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters.
    Daws LC; Callaghan PD; Morón JA; Kahlig KM; Shippenberg TS; Javitch JA; Galli A
    Biochem Biophys Res Commun; 2002 Feb; 290(5):1545-50. PubMed ID: 11820798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysregulation of dopamine transporter trafficking and function after abstinence from cocaine self-administration in rats: evidence for differential regulation in caudate putamen and nucleus accumbens.
    Samuvel DJ; Jayanthi LD; Manohar S; Kaliyaperumal K; See RE; Ramamoorthy S
    J Pharmacol Exp Ther; 2008 Apr; 325(1):293-301. PubMed ID: 18198344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Voltammetric assessment of dopamine clearance in the absence of the dopamine transporter: no contribution of other transporters in core or shell of nucleus accumbens.
    Mateo Y; Budygin EA; John CE; Banks ML; Jones SR
    J Neurosci Methods; 2004 Dec; 140(1-2):183-7. PubMed ID: 15589348
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
    Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
    J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
    Jaber M; Bloch B; Caron MG; Giros B
    C R Seances Soc Biol Fil; 1998; 192(6):1127-37. PubMed ID: 10101608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A triple mutation in the second transmembrane domain of mouse dopamine transporter markedly decreases sensitivity to cocaine and methylphenidate.
    Chen R; Han DD; Gu HH
    J Neurochem; 2005 Jul; 94(2):352-9. PubMed ID: 15998286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons.
    Ingram SL; Prasad BM; Amara SG
    Nat Neurosci; 2002 Oct; 5(10):971-8. PubMed ID: 12352983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Covalent and noncovalent chemical modifications of arginine residues decrease dopamine transporter activity.
    Volz TJ; Kim M; Schenk JO
    Synapse; 2004 Jun; 52(4):272-82. PubMed ID: 15103693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.